References
- Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study. J Am Coll Cardiol 2013;62(11):1002-12
- Kapelouzou A, Cokkinos D. Can we modify the course towards aortic stenosis? Hellenic J Cardiol 2013;54(4):239-41
- Cowell SJ, Newby DE, Burton J, et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003;58(9):712-16
- Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359(13):1343-56
- Chan KL, Teo K, Dumesnil JG, et al. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: Results of the aortic stenosis progression observation: Measuring effects of rosuvastatin (astronomer) trial. Circulation 2010;121(2):306-14
- Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90(2):844-53
- Dweck MR, Jenkins WS, Vesey AT, et al. 18f-naf uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7(2):371-8
- Dweck MR, Jones C, Joshi NV, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125(1):76-86
- Clavel MA, Pibarot P, Messika-Zeitoun D, et al. Impact of aortic valve calcification, as measured by mdct, on survival in patients with aortic stenosis: Results of an international registry study. J Am Coll Cardiol 2014;64(12):1202-13
- Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107(17):2181-4
- Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171(5):1407-18
- Persy V, D’haese P. Vascular calcification and bone disease: The calcification paradox. Trends Mol Med 2009;15(9):405-16
- Aksoy Y, Yagmur C, Tekin GO, et al. Aortic valve calcification: Association with bone mineral density and cardiovascular risk factors. Coron Artery Dis 2005;16(6):379-83
- Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89(2):309-19
- Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12(9):1260-8
- Kaden JJ, Bickelhaupt S, Grobholz R, et al. Receptor activator of nuclear factor kappab ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004;36(1):57-66
- Whyte MP. Paget’s disease of bone and genetic disorders of rankl/opg/rank/nf-kappab signaling. Ann N Y Acad Sci 2006;1068:143-64
- Demer LL, Tintut Y. Vascular calcification: Pathobiology of a multifaceted disease. Circulation 2008;117(22):2938-48
- Johnson K, Polewski M, Van Etten D, Terkeltaub R. Chondrogenesis mediated by ppi depletion promotes spontaneous aortic calcification in npp1-/- mice. Arterioscler Thromb Vasc Biol 2005;25(4):686-91
- Elmariah S, Delaney JA, O’brien KD, et al. Bisphosphonate use and prevalence of valvular and vascular calcification in women mesa (the multi-ethnic study of atherosclerosis). J Am Coll Cardiol 2010;56(21):1752-9
- Sterbakova G, Vyskocil V, Linhartova K. Bisphosphonates in calcific aortic stenosis: Association with slower progression in mild disease–a pilot retrospective study. Cardiology 2010;117(3):184-9
- Aksoy O, Cam A, Goel SS, et al. Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol 2012;59(16):1452-9
- Cummings SR, San Martin J, Mcclung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361(8):756-65
- Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. (SALTIRE II). Available from: https://clinicaltrials.gov/ct2/show/NCT02132026